Literature DB >> 1618752

Stimulation of sphingomyelin biosynthesis by brefeldin A and sphingomyelin breakdown by okadaic acid treatment of rat hepatocytes.

G M Hatch1, D E Vance.   

Abstract

Studies on sphingomyelin metabolism in rat hepatocytes were facilitated by the use of choline-deficient cells which allowed for the rapid labeling of phosphatidylcholine and as a result sphingomyelin. Pulse and pulse-chase studies with [methyl-3H]choline and [methyl-3H]methionine demonstrated that both compounds were effectively used for sphingomyelin biosynthesis and that newly made and pre-existing phosphatidylcholine could be used for sphingomyelin biosynthesis. When hepatocytes were incubated with brefeldin A, there was a 2.4-fold stimulation of the conversion of phosphatidylcholine into sphingomyelin. Since brefeldin A causes collapse of the cis/medial Golgi into the endoplasmic reticulum the stimulation of sphingomyelin biosynthesis could be due to more rapid access of the labeled phosphatidylcholine in the endoplasmic reticulum to sphingomyelin synthase in the collapsed Golgi. Forskolin inhibited the brefeldin A-induced stimulation of sphingomyelin biosynthesis. To investigate whether or not phosphorylation reactions regulate sphingomyelin metabolism, hepatocytes were incubated with okadaic acid, a potent inhibitor of protein phosphatases 1 and 2A. Rather than stimulating sphingomyelin biosynthesis, okadaic acid enhanced the catabolism of sphingomyelin. In contrast, a cyclic AMP analogue and forskolin had no effect on sphingomyelin biosynthesis or catabolism. Surprisingly, other pulse-chase studies demonstrated that okadaic acid stimulated the catabolism of only newly made sphingomyelin. The brefeldin A and okadaic acid effects were independent of lysosomal involvement. Subcellular fractionation studies revealed that brefeldin A and okadaic acid effects were generalized in all sphingomyelin containing membranes. The brefeldin A studies suggest that the rate of transfer of phosphatidylcholine from the endoplasmic reticulum to the Golgi might be limiting for sphingomyelin biosynthesis. The okadaic acid studies indicate that the catabolism of sphingomyelin by a sphingomyelinase is regulated by an unidentified protein kinase and by either protein phosphatase 1 and/or 2A activity in hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618752

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Sphingomyelin synthase 1 activity is regulated by the BCR-ABL oncogene.

Authors:  Tara Ann Burns; Marimuthu Subathra; Paola Signorelli; Young Choi; Xiaofeng Yang; Yong Wang; Maristella Villani; Kapil Bhalla; Daohong Zhou; Chiara Luberto
Journal:  J Lipid Res       Date:  2012-11-16       Impact factor: 5.922

2.  Bcr-Abl regulation of sphingomyelin synthase 1 reveals a novel oncogenic-driven mechanism of protein up-regulation.

Authors:  Sitapriya Moorthi; Tara Ann Burns; Gui-Qin Yu; Chiara Luberto
Journal:  FASEB J       Date:  2018-03-13       Impact factor: 5.191

3.  Mifepristone treatment results in differential regulation of glycerolipid biosynthesis in baby hamster kidney cells expressing a mifepristone-inducible ABCA1.

Authors:  Kristin D Hauff; Ryan W Mitchell; Fred Y Xu; Thomas Dembinski; David Mymin; Xiaohui Zha; Patrick C Choy; Grant M Hatch
Journal:  Lipids       Date:  2011-06-28       Impact factor: 1.880

4.  Differential effects of chloroquine on cardiolipin biosynthesis in hepatocytes and H9c2 cardiac cells.

Authors:  T K Ross; F Y Xu; W A Taylor; G M Hatch
Journal:  Mol Cell Biochem       Date:  2000-04       Impact factor: 3.396

5.  Host cell phospholipids are trafficked to and then modified by Chlamydia trachomatis.

Authors:  J L Wylie; G M Hatch; G McClarty
Journal:  J Bacteriol       Date:  1997-12       Impact factor: 3.490

Review 6.  Approaches for probing and evaluating mammalian sphingolipid metabolism.

Authors:  Justin M Snider; Chiara Luberto; Yusuf A Hannun
Journal:  Anal Biochem       Date:  2019-03-24       Impact factor: 3.365

7.  Acute perturbations in Golgi organization impact de novo sphingomyelin synthesis.

Authors:  Suchismita Chandran; Carolyn E Machamer
Journal:  Traffic       Date:  2008-08-09       Impact factor: 6.215

8.  Transport of newly synthesized glucosylceramide to the plasma membrane by a non-Golgi pathway.

Authors:  D E Warnock; M S Lutz; W A Blackburn; W W Young; J U Baenziger
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

9.  Phospholipid composition of purified Chlamydia trachomatis mimics that of the eucaryotic host cell.

Authors:  G M Hatch; G McClarty
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

10.  C. trachomatis-infection accelerates metabolism of phosphatidylcholine derived from low density lipoprotein but does not affect phosphatidylcholine secretion from hepatocytes.

Authors:  Grant M Hatch; Grant McClarty
Journal:  BMC Microbiol       Date:  2004-02-17       Impact factor: 3.605

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.